BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 29, 2002
View Archived Issues
Ricerca's Infectious Disease Area Established Via Deal With Genset
Read More
Transgenic Mouse Experiments Show Clusterin Protein Has Hand In Alzheimer's Plaque Formation
Read More
Scios Planning Private Offering Of $125M In Convertible Notes
Read More
Other News To Note
Read More
Quarterly Earnings Reports
Read More
OGS Gains European Approval, Partner For Gaucher's Product
LONDON - Oxford GlycoSciences plc said Friday it received approval in Europe for Vevesca, an oral treatment for Gaucher's disease that was turned down by the FDA on June 24. (BioWorld Today)
Read More